ESG

With a new CEO and a key investor conference ahead, Metagenomi bets on its unique metagenomics platform and a hemophilia drug to navigate a tough market.

Top veterinary group endorses Visbiome Vet for chronic gut issues, setting a new evidence-based standard in a crowded, unregulated pet supplement market.

As corporate dentistry grows, one Ann Arbor practice's shift to woman-owned leadership highlights a demand for personalized, health-focused cosmetic care.

Over 1,000 professionals are in Chicago for the NeighborWorks Training Institute, bringing a $5.2M economic boost and new strategies for the housing crisis.

The company commercializes two new recycled plastics from 100% post-consumer film, boosting sustainable packaging options amid soaring market demand.

A massive $12 billion data center investment from Amazon and STACK Infrastructure promises economic renewal for northwest Louisiana, but raises critical questions.

A former Regeneron exec who built a blockbuster drug joins a medtech startup, signaling a major push to disrupt the multi-billion dollar chemo-port market.

Beaver Street Fisheries sheds its legacy name for BSF, a strategic shift reflecting its $800M global operation and role in a complex seafood supply chain.

Celebrating 10 years, Maryland's first proton center has treated 6,000 patients by blending advanced technology with a unique model for affordable care.

The Ontario pension giant posted a 6% return, growing assets to $145B, while boosting Canadian investments and charting a course to a greener portfolio.

Stäubli's new mobile robot promises to revolutionize sterile drug manufacturing, tackling contamination risks and boosting efficiency in the industry's cleanest rooms.

With vet emergencies costing thousands, a new AKC initiative provides a lifeline to low-income owners facing impossible financial decisions.

With 30+ years of experience, Bobb Campbell takes the helm at Cambrian to scale its water reuse solutions amid growing global demand and regulatory pressure.

The company's revenue skyrocketed, but SEC filings reveal a story of significant liquidity risks and a bold gamble on the booming wellness market.

After gaining FDA alignment, INmune Bio is advancing its inflammation-targeting drug, XPro1595, offering a novel and potentially safer approach for patients.

Led by decorated medallists Mollie Jepsen and Alexis Guimond, Canada's eight-skier Para alpine team blends veteran grit with rising stars for Italy.

Soar Autism Center launches a free, 40-hour RBT course focused on the play-based ESDM model, tackling workforce shortages and raising care standards.

The architect of Tesla's dry electrode acquisition is back, betting on AM Batteries' DBE 2.0 to revolutionize how batteries are made. Here's why.

Solana Company is building a massive infrastructure in Asia, but can this bold, high-risk play conquer the complex regulatory landscape and win the race?

The iconic Vienna roaster says its coffee is 100% 'responsibly selected.' We explore what this means for the industry, farmers, and your daily cup.